Boston Scientific is keeping the ball rolling in pulsed field ablation, posting 177% electrophysiology growth in the third ...
Boston Scientific (NYSE:BSX) shares were down 5% in morning trading Wednesday following news that the company has paused a ...
In December 2023, Boston Scientific Corporation (NYSE: BSX) initiated the AVANT GUARD trial to evaluate the safety and ...
Demand for the pulsed field ablation device drove the company’s electrophysiology sales up 177% in the third quarter compared ...
WNEM Saginaw on MSN7d
Farapulse: Smartbombs blasting AFibThat was his first sign of AFib. After a failed traditional ablation procedure, Copley was one of the first to have Farapulse ...
Boston Scientific received FDA approval for its navigation-enabled Farawave Nav ablation catheter and clearance for new ...
Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial ...
Despite a trial pause, Boston Scientific's impressive Q3 results and strategic expansions hint at a promising growth ...
William Plovanic, an analyst from Canaccord Genuity, maintained the Buy rating on Boston Scientific (BSX – Research Report). The ...
Boston Scientific Corp. posted another eye-popping quarterly report, led by a 177% year-over-year increase in its ...
Boston Scientific Corp. racked up a two-fer from the U.S. FDA with approval of its navigation-enabled Farawave Nav ablation catheter and 510(k) clearance for the Faraview software for use with its ...
SGMC Health recently announced Kamil Hanna, MD, a cardiac electrophysiologist, has successfully performed the first Farapulse ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback